Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 2008 Aug 1;118(8):2986. doi: 10.1172/JCI33637C1

Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells

Hewang Li, Ines Armando, Peiying Yu, Crisanto Escano, Susette C Mueller, Laureano Asico, Annabelle Pascua, Quansheng Lu, Xiaoyan Wang, Van Anthony M Villar, John E Jones, Zheng Wang, Ammasi Periasamy, Yuen-Sum Lau, Patricio Soares-da-Silva, Karen Creswell, Gaétan Guillemette, David R Sibley, Gilbert Eisner, John J Gildea, Robin A Felder, Pedro A Jose
PMCID: PMC2491658

Original citation: J. Clin. Invest. 118:2180-2189 (2008). doi:10.1172/JCI33637.

Citation for this corrigendum: J. Clin. Invest. 118:2986 (2008). doi:10.1172/JCI33637C1.

During the preparation of the manuscript, John J. Gildea’s name was inadvertently omitted from the author list. Gildea is affiliated with the Department of Pathology, University of Virginia Health Sciences Center, Charlottesville, Virginia, USA. The correct author list appears above.

The authors regret the error.

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES